|
ASCC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.256800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.448000E-01 |
| Normal-vs-Stage2 |
3.164800E-01 |
| Normal-vs-Stage3 |
8.156800E-01 |
| Normal-vs-Stage4 |
5.134800E-01 |
| Stage1-vs-Stage2 |
3.029200E-01 |
| Stage1-vs-Stage3 |
8.388800E-01 |
| Stage1-vs-Stage4 |
6.594600E-01 |
| Stage2-vs-Stage3 |
5.900200E-01 |
| Stage2-vs-Stage4 |
8.914600E-01 |
| Stage3-vs-Stage4 |
7.782800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.767000E-01 |
| Normal-vs-AfricanAmerican |
6.971800E-01 |
| Normal-vs-Asian |
8.252200E-01 |
| Caucasian-vs-AfricanAmerican |
6.433800E-01 |
| Caucasian-vs-Asian |
8.581600E-01 |
| AfricanAmerican-vs-Asian |
7.147600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.504600E-01 |
| Normal-vs-Female |
1.814800E-01 |
| Male-vs-Female |
2.132300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.552200E-01 |
| Normal-vs-Extreme_Weight |
5.230600E-01 |
| Normal-vs-Obese |
5.869000E-01 |
| Normal-vs-Extreme_Obese |
9.240300E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.331600E-01 |
| Normal_Weight-vs-Obese |
1.035820E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.024800E-01 |
| Extreme_Weight-vs-Obese |
2.300000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.911000E-01 |
| Obese-vs-Extreme_Obese |
9.106400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.940200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.945400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.575000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.728400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.855600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.278230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.775770E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.486200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.405000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.886430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.775400E-01 |
| Normal-VS-Type2 PRCC |
1.502750E-01 |
| Normal-VS-KIRP CIMP |
7.723600E-02 |
| Normal-VS-Unclassified PRCC |
2.324400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.380200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.602790E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.600390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.327720E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.945570E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.198800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.571640E-01 |
| Normal-vs-N1 |
9.080800E-01 |
| Normal-vs-N2 |
8.885000E-01 |
| N0-vs-N1 |
1.967610E-01 |
| N0-vs-N2 |
6.475800E-01 |
| N1-vs-N2 |
8.741200E-01 |
|
|
